Search Results - "Pulpon, L.A."

72: Changes in Lipid Profiles Associated with Everolimus- and MMF-Based Immunosuppression Are Clinically Comparable in De Novo Cardiac Transplant Recipients by Magnani, G, Almenar, L, Vigano, M, Maccherini, M, Pulpon, L.A, Musumeci, F, Gerosa, G, Lehmkuhl, H, Livi, U

Get full text

367: Lung Cancer after Heart Transplantation: Incidence and Prognosis. Data from the Spanish Post-Heart-Transplant Tumour Registry by Crespo-Leiro, M.G, Manito, N, Rabago, G, Almenar-Bonet, L, Alonso-Pulpon, L.A, Mirabet, S, Fernandez-Yanez, J, Diaz-Molina, B, Gonzalez-Vilchez, F, Romero, N, Arizon, J.M, Delgado, J.F, Roig, E, Blasco, T, Pascual-Figal, D.A, de la Fuente-Galan, L, Muniz, J

Get full text

298: Usefulness of mTOR Inhibitors for Treatment of Heart Transplant Patients with Non-Cutaneous Non-Lymphomatous Tumours: Data from the Spanish Post-Heart-Transplant Tumour Registry by Crespo-Leiro, M.G, Alonso-Pulpon, L.A, Brosa, V, Fernandez-Yanez, J, Almenar-Bonet, L, Fernandez-Vilchez, F, Delgado, J.F, Manito, N, Diaz-Molina, B, Rabago, G, Arizon, J.M, Romero, N, Roig, E, Blasco, T, Pascual, D, Muniz, J

Get full text

181: Pre-existing neoplasms and risk for malignancy after heart transplantation. Data from the Spanish Post-Heart Transplant Tumors Registry by Delgado, J.F, Crespo, M.G, Pulpon, L.A, Arizon, J.M, Almenar, L, Palomo, J, Manito, N, Rabago, G, Lage, E, Diaz, B, Roig, E, Pascual, D, Blasco, T, Fuente, L, Vals, M, Camprecios, M, Muniz, J

Get full text

Superior Prevention of Acute Rejection by Tacrolimus vs. Cyclosporine in Heart Transplant Recipients—A Large European Trial by Grimm, M., Rinaldi, M., Yonan, N. A., Arpesella, G., Arizón Del Prado, J. M., Pulpón, L. A., Villemot, J. P., Frigerio, M., Rodriguez Lambert, J. L., Crespo‐Leiro, M. G., Almenar, L., Duveau, D., Ordonez‐Fernandez, A., Gandjbakhch, J., Maccherini, M., Laufer, G.

“…We compared efficacy and safety of tacrolimus (Tac)‐based vs. cyclosporine (CyA) microemulsion‐based immunosuppression in combination with azathioprine (Aza)…”
Get full text

Incidence and Risk Factors for Nonmelanoma Skin Cancer After Heart Transplantation by Molina, B.D, Leiro, M.G.C, Pulpón, L.A, Mirabet, S, Yañez, J.F, Bonet, L.A, Vilchez, F.G, Delgado, J.F, Manito, N, Rábago, G, Arizón, J.M, Romero, N, Roig, E, Blasco, T, Pascual, D, de la Fuente, L, Muñiz, J

“…Abstract Introduction The incidence of skin cancer in heart transplant (HT) patients is higher than in the general population, reversing the proportion of…”
Get full text

680 Long Term Results with Bosentan Treatment in Pulmonary Hypertension by Segovia Cubero, J, Avellana Calvo, P.M, Sufrate Sorzano, E, Gomez Bueno, M, García-Pavía, P., M.D, Cosio Carmena, G, Gutierrez Landaluce, C, Alonso Pulpón, L.A

Get full text

564 Desmosomal Protein Gene Mutations in Patients with Idiopathic Dilated Cardiomyopathy Undergoing Cardiac Transplantation: A Clinicopathological Study by Garcia-Pavia, P, Segovia, J, Syrris, P, Salas, C, Mirelis, J.G, Gomez-Bueno, M, Vilches, C, Cobo-Marcos, M, Garcia-Cosio Carmena, M.D, Avellana, P, Bornstein, B, Elliott, P.M, Alonso Pulpón, L.A

Get full text

392 Genetic Basis of Heart Transplanted Hypertrophic Cardiomyopathy by Garcia-Pavia, P, Segovia, J, Vazquez, M.E, Salas, C, Avellana, P, Gomez-Bueno, M, Gallardo, E, Garcia-Cosio Carmena, M.D, Cobo-Marcos, M, Vilches, C, Garesse, R, Molano, J, Bornstein, B, Alonso Pulpón, L.A

Get full text

The Prognosis of Noncutaneous, Nonlymphomatous Malignancy After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumour Registry by Crespo-Leiro, M.G, Alonso-Pulpón, L.A, Villa-Arranz, A, Brossa-Loidi, V, Almenar-Bonet, L, González-Vilchez, F, Delgado-Jiménez, J.F, Manito-Lorite, N, Díaz-Molina, B, Rábago, G, Arizón-del Prado, J.M, Romero-Rodríguez, N, Brossa, V, Blasco-Peiró, T, Pascual-Figal, D, de la Fuente-Galán, L, Muñiz-García, J

“…Abstract Introduction Malignancy is a major complication in the management of solid organ transplant patients. Skin cancers show a better prognosis than other…”
Get full text

Steroid Use in Heart Transplant Patients in Spain in the Current Era: A Multicenter Survey by Crespo-Leiro, M, Delgado, J, Almenar, L, Arizón, J.M, Blasco, T, Brossa, V, De la Fuente, L, Díaz, B, Fernández-Yañez, J, Garrido, I.P, Gómez Bueno, M, González Vílchez, F, Lage, E, López López, L, Mirabet, S, Pérez-Villa, F, Pulpón, L.A, Roig, E, Vázquez de Prada, J.A

“…Abstract Objective Steroid withdrawal (SW) from maintenance therapy in heart transplant patients is still a controversial subject. We designed a questionnaire…”
Get full text

220. Asistencia univentricular izquierda Berlin heart como puente al trasplante en pacientes con hipertensión pulmonar grave by Martínez Cabeza, P, Castedo Mejuto, E, Ramis Pocovi, S, López Fernández, J, Serrano-Fiz García, S, García Montero, C, Burgos Lázaro, R.J, Gómez Bueno, M, Segovia Cubero, J, Pulpón, L.A, Ugarte Basterrechea, J

“…La hipertensión pulmonar (HTP) grave es un factor de riesgo de mortalidad perioperatoria durante el trasplante cardíaco (TC). Los pacientes con HTP refractaria…”
Get full text

410 Biventricular pacing: medium term follow-up by Fernandez Lozano, I., Escudier, J.M., Toquero, J., Mo ivas, V., Blasco, A., Ortiz, P., Castedo, E., Pulpon, L.A.

Get full text

481 Posterior wall of left atrium and pulmonary veins refractory period is related to atrial fibrillation inducibility in pigs by Fernandez Lozano, I., Escudier, J.M., Toquero, J., Escudero, C., Mo ivas, V., Ortiz, P., Castedo, E., Pulpon, L.A.

Get full text

Pulmonary nocardiosis in heart transplant recipients: treatment and outcome by Peraira, J.R, Segovia, J, Fuentes, R, Jiménez-Mazuecos, J, Arroyo, R, Fuertes, B, Mendaza, P, Pulpon, L.A

“…Nocardial infections typically affect patients receiving immunosupressants, occurring early after surgery in 3% to 40% of heart transplant (HTx) recipients…”
Get full text

Heart transplantation: our experience in 450 cases by Roda, J.R, Castedo, E, Tellez, J.C, Burgos, R, Serrano-Fiz, S, Montero, C.G, Tellez, G, Segovia, J, Pulpon, L.A, Ugarte, J

Get full text

Current induction immunosuppression and post-heart transplant lymphoproliferative disorders by Peraira, J.R, Segovia, J, Fuertes, B, Fernández, J.A, Escudier, J.M, Salas, C, Pulpón, L.A

“…The use of high-dose OKT3 has been reported to be associated with a high incidence of posttransplant lymphoproliferative disorders (PTLD) in heart…”
Get full text

Differential characteristics of heart transplantation in patients older than 60 years by Peraira, J.R, Segovia, J, Fuentes, R, Ortiz, P, Ortigosa, J, Silva, L, Cañas, A, Pulpón, L.A

“…The effect of advanced age on the results of heart transplantation (HTx) is still controversial. The few articles addressing this issue have not been…”
Get full text

Primary graft failure in heart transplantation: a multivariate analysis by Segovia, J, Pulpón, L.A, Sanmartı́n, M, Tejero, C, Serrano, S, Burgos, R, Castedo, E, Ugarte, J

Get full text

P78 - 220. Asistencia univentricular izquierda Berlin heart como puente al trasplante en pacientes con hipertensión pulmonar grave by Martínez Cabeza, P., Castedo Mejuto, E., Ramis Pocovi, S., López Fernández, J., Serrano-Fiz García, S., García Montero, C., Burgos Lázaro, R.J., Gómez Bueno, M., Segovia Cubero, J., Pulpón, L.A., Ugarte Basterrechea, J.

“…La hipertensión pulmonar (HTP) grave es un factor de riesgo de mortalidad perioperatoria durante el trasplante cardíaco (TC). Los pacientes con HTP refractaria…”
Get full text